Utility of Endobronchial Ultrasound in Assessment of Intrathoracic Lesions in Paediatric Patients.


Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
Historique:
received: 17 02 2019
accepted: 10 06 2019
pubmed: 15 8 2019
medline: 23 9 2020
entrez: 15 8 2019
Statut: ppublish

Résumé

In adults, linear endobronchial ultrasound (EBUS) is the preferred modality to sample intrathoracic adenopathy and radial EBUS is a useful tool to biopsy peripheral pulmonary nodules. Utility in children is less well known. The objective of this study was to review the EBUS experience of two specialist centres to better define the current role of EBUS in paediatric practice. A retrospective record review of EBUS procedures undertaken in patients aged 0-17 years at the Royal Children's Hospital (Melbourne, Australia) and Thoraxklinik (Heidelberg, Germany) was performed. Data extracted included patient demographics, clinical presentation, bronchoscope (size and model), EBUS technique used, pathologic results, need for further invasive investigation, and complications. Between 2008 and 2017, ten EBUS procedures were performed (6 linear EBUS and 4 radial EBUS). No complications were reported. Linear EBUS was performed on subjects who were between 4 and 15 years old, with a 100% diagnostic yield. Radial EBUS was non-diagnostic in three cases of non-malignant disease. In one case, it was used successfully for imaging alone. Both linear and radial EBUS are safe and feasible in children. Diagnostic yield of linear EBUS was 100%. Radial EBUS did not demonstrate utility, likely reflecting the pathologies of underlying parenchymal masses in paediatric populations.

Identifiants

pubmed: 31412340
pii: 000501466
doi: 10.1159/000501466
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-346

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Shivanthan Shanthikumar (S)

Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia, shivanthan.shanthikumar@rch.org.au.
Respiratory Diseases, Murdoch Children's Research Institute, Melbourne, Victoria, Australia, shivanthan.shanthikumar@rch.org.au.
Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia, shivanthan.shanthikumar@rch.org.au.

John Massie (J)

Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.
Respiratory Diseases, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

Sarath Ranganathan (S)

Respiratory and Sleep Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.
Respiratory Diseases, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

Maren Schuhmann (M)

Department of Pneumology and Critical Care Medicine, Thoraxklinik, Heidelberg, Germany.
Translational Lung Research Center, University of Heidelberg, Heidelberg, Germany.

Ralf Eberhardt (R)

Department of Pneumology and Critical Care Medicine, Thoraxklinik, Heidelberg, Germany.
Translational Lung Research Center, University of Heidelberg, Heidelberg, Germany.

Louis B Irving (LB)

Department of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.

Felix J F Herth (FJF)

Department of Pneumology and Critical Care Medicine, Thoraxklinik, Heidelberg, Germany.
Translational Lung Research Center, University of Heidelberg, Heidelberg, Germany.

Daniel P Steinfort (DP)

Department of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH